Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy

Science Translational Medicine

Volumn 8, Issue 351, 2016, Pages

  Chhabra, Akanksha ^a   Ring, Aaron M ^a,b   Weiskopf, Kipp ^a,b   Schnorr, Peter John ^a   Gordon, Sydney ^a,b   Le, Alan C ^a   Kwon, Hye Sook ^a   Ring, Nan Guo ^a,b   Volkmer, Jens ^a,b   Ho, Po Yi ^a,b   Tseng, Serena ^a,b   Weissman, Irving L ^a,b   Shizuru, Judith A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD47 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; DNA BINDING PROTEIN; FC RECEPTOR; RAG2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CELL COUNT; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL ADHESION; CELL HOMING; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; EMBRYO; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECIPIENT; REGENERATIVE MEDICINE; TUMOR ENGRAFTMENT; ANIMAL; ANTAGONISTS AND INHIBITORS; ERYTHROCYTE; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOTHERAPY; METABOLISM; MUTANT MOUSE STRAIN; PHYSIOLOGY; PROCEDURES;

ANIMALS; CD47 ANTIGEN; DNA-BINDING PROTEINS; ERYTHROCYTES; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY; MICE; MICE, MUTANT STRAINS; RECEPTORS, FC;

EID: 84983423591     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aae0501     Document Type: Article

References (38)

1. J. A. Shizuru, R. S. Negrin, I. L. Weissman, Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56, 509-538 (2005).
2. C. K. F. Chan, C.-C. Chen, C. A. Luppen, J.-B. Kim, A. T. DeBoer, K. Wei, J. A. Helms, C. J. Kuo, D. L. Kraft, I. L. Weissman, Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457, 490-494 (2009).
3. C. K. F. Chan, E. Y. Seo, J. Y. Chen, D. Lo, A. McArdle, R. Sinha, R. Tevlin, J. Seita, J. Vincent-Tompkins, T. Wearda, W.-J. Lu, K. Senarath-Yapa, M. T. Chung, O. Marecic, M. Tran, K. S. Yan, R. Upton, G. G. Walmsley, A. S. Lee, D. Sahoo, C. J. Kuo, I. L. Weissman, M. T. Longaker, Identification and specification of the mouse skeletal stem cell. Cell 160, 285-298 (2015).
4. D. Bhattacharya, L. I. Ehrlich, I. L. Weissman, Space-time considerations for hematopoietic stem cell transplantation. Eur. J. Immunol. 38, 2060-2067 (2008).
5. H. J. Deeg; Seattle Marrow Transplant Team, Acute and delayed toxicities of total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 9, 1933-1939 (1983).
6. G. Socié, N. Salooja, A. Cohen, A. Rovelli, E. Carreras, A. Locasciulli, E. Korthof, J. Weis, V. Levy, A. Tichelli; Late Effects Working Party of the European Study Group for Blood and Marrow Transplantation, Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101, 3373-3385 (2003).
7. J. A. Shizuru, L. Jerabek, C. T. Edwards, I. L. Weissman, Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2, 3-14 (1996).
8. I. Weissman, Stem Cell Research: Paths to cancer therapies and regenerative medicine. JAMA 294, 1359-1366 (2005).
9. S. Okada, H. Nakauchi, K. Nagayoshi, S. Nishikawa, S. Nishikawa, Y. Miura, T. Suda, Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78, 1706-1712 (1991).
10. D. Kent, M. Copley, C. Benz, B. Dykstra, M. Bowie, C. Eaves, Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin. Cancer Res. 14, 1926-1930 (2008).
11. J. Domen, I. L. Weissman, Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J. Exp. Med. 192, 1707-1718 (2000).
12. E. A. McCulloch, L. Siminovitch, J. E. Till, Spleen-colony formation in anemic mice of genotype WW. Science 144, 844-846 (1964).
13. L. A. Thorén, K. Liuba, D. Bryder, J. M. Nygren, C. T. Jensen, H. Qian, J. Antonchuk, S.-E. W. Jacobsen, Kit regulates maintenance of quiescent hematopoietic stem cells. J. Immunol. 180, 2045-2053 (2008).
14. S. L. Hall, K.-H. W. Lau, S.-T. Chen, J. C. Felt, D. S. Gridley, J.-K. Yee, D. J. Baylink, An improved mouse Sca-1+ cell-based bone marrow transplantation model for use in gene- and cell-based therapeutic studies. Acta Haematol. 117, 24-33 (2007).
15. C. Waskow, V. Madan, S. Bartels, C. Costa, R. Blasig, H.-R. Rodewald, Hematopoietic stem cell transplantation without irradiation. Nat. Methods 6, 267-269 (2009).
16. K. N. Cosgun, S. Rahmig, N. Mende, S. Reinke, I. Hauber, C. Schäfer, A. Petzold, H. Weisbach, G. Heidkamp, A. Purbojo, R. Cesnjevar, A. Platz, M. Bornhäuser, M. Schmitz, D. Dudziak, J. Hauber, J. Kirberg, C. Waskow, Kit regulates HSC engraftment across the human-mouse species barrier. Cell Stem Cell 15, 227-238 (2014).
17. L. Ding, T. L. Saunders, G. Enikolopov, S. J. Morrison, Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462 (2012).
18. A. Czechowicz, D. Kraft, I. L. Weissman, D. Bhattacharya, Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318, 1296-1299 (2007).
19. S. C. Derderian, P. P. Togarrati, C. King, P. W. Moradi, D. Reynaud, A. Czechowicz, I. L. Weissman, T. C. MacKenzie, In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice. Blood 124, 973-980 (2014).
20. X. Xue, N. K. Pech, W. C. Shelley, E. F. Srour, M. C. Yoder, M. C. Dinauer, Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice. Blood 116, 5419-5422 (2010).
21. M. P. Chao, R. Majeti, I. L. Weissman, Programmed cell removal: A new obstacle in the road to developing cancer. Nat. Rev. Cancer 12, 58-67 (2012).
22. P. Jiang, C. F. Lagenaur, V. Narayanan, Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 274, 559-562 (1999).
23. E. J. Brown, W. A. Frazier, Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11, 130-135 (2001).
24. S. Jaiswal, C. H. M. Jamieson, W. W. Pang, C. Y. Park, M. P. Chao, R. Majeti, D. Traver, N. van Rooijen, I. L. Weissman, CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138, 271-285 (2009).
25. R. Majeti, M. P. Chao, A. A. Alizadeh, W. W. Pang, S. Jaiswal, K. D. Gibbs Jr., N. van Rooijen, I. L. Weissman, CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286-299 (2009).
26. S. B. Willingham, J.-P. Volkmer, A. J. Gentles, D. Sahoo, P. Dalerba, S. S. Mitra, J. Wang, H. Contreras-Trujillo, R. Martin, J. D. Cohen, P. Lovelace, F. A. Scheeren, M. P. Chao, K. Weiskopf, C. Tang, A. K. Volkmer, T. J. Naik, T. A. Storm, A. R. Mosley, B. Edris, S. M. Schmid, C. K. Sun, M.-S. Chua, O. Murillo, P. Rajendran, A. C. Cha, R. K. Chin, D. Kim, M. Adorno, T. Raveh, D. Tseng, S. Jaiswal, P. Ø. Enger, G. K. Steinberg, G. Li, S. K. So, R. Majeti, G. R. Harsh, M. van de Rijn, N. N. Teng, J. B. Sunwoo, A. A. Alizadeh, M. F. Clarke, I. L. Weissman, The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. U.S.A. 109, 6662-6667 (2012).
27. K. Weiskopf, A. M. Ring, C. C. M. Ho, J.-P. Volkmer, A. M. Levin, A. K. Volkmer, E. Özkan, N. B. Fernhoff, M. van de Rijn, I. L. Weissman, K. C. Garcia, Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341, 88-91 (2013).
28. M. Okura, H. Maeda, S.-i. Nishikawa, M. Mizoguchi, Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J. Invest. Dermatol. 105, 322-328 (1995).
29. A. Pincetic, S. Bournazos, D. J. DiLillo, J. Maamary, T. T. Wang, R. Dahan, B.-M. Fiebiger, J. V. Ravetch, Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 15, 707-716 (2014).
30. D. J. DiLillo, J. V. Ravetch, Fc-receptor interactions regulate both cytotoxic and immuno-modulatory therapeutic antibody effector functions. Cancer Immunol. Res. 3, 704-713 (2015).
31. A. M. Scott, J. D. Wolchok, L. J. Old, Antibody therapy of cancer. Nat. Rev. Cancer 12, 278-287 (2012).
32. T. Takai, M. Li, D. Sylvestre, R. Clynes, J. V. Ravetch, FcR g chain deletion results in pleiotrophic effector cell defects. Cell 76, 519-529 (1994).
33. + and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 112, 258-267 (2004).
34. A. M. S. Müller, J. Poyser, N. J. Küpper, C. Burnett, R. M. Ko, H. E. Kohrt, M. Florek, P. Zhang, R. S. Negrin, J. A. Shizuru, Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood 123, 2882-2892 (2014).
35. M. T. Baldridge, K. Y. King, N. C. Boles, D. C. Weksberg, M. A. Goodell, Quiescent haematopoietic stem cells are activated by IFN-g in response to chronic infection. Nature 465, 793-797 (2010).
36. M. Magnani, L. Rossi, V. Stocchi, L. Cucchiarini, G. Piacentini, G. Fornaini, Effect of age on some properties of mice erythrocytes. Mech. Ageing Dev. 42, 37-47 (1988).
37. J. Liu, L. Wang, F. Zhao, S. Tseng, C. Narayanan, L. Shura, S. Willingham, M. Howard, S. Prohaska, J. Volkmer, M. Chao, I. L. Weissman, R. Majeti, Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLOS One 10, e0137345 (2015).
38. + dose. Bone Marrow Transplant. 48, 508-513 (2013).